CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $23,000 | -54.0% | 127,922 | -28.2% | 0.00% | -50.0% |
Q2 2022 | $50,000 | +31.6% | 178,184 | +59.5% | 0.00% | +33.3% |
Q1 2022 | $38,000 | +15.2% | 111,749 | +397.1% | 0.00% | 0.0% |
Q3 2021 | $33,000 | -19.5% | 22,480 | +8.4% | 0.00% | -25.0% |
Q2 2021 | $41,000 | -58.6% | 20,745 | -49.8% | 0.00% | -42.9% |
Q1 2021 | $99,000 | – | 41,310 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 534,148 | $951,000 | 0.36% |
CVI Holdings, LLC | 415,652 | $740,000 | 0.14% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 61,307 | $109,000 | 0.01% |
Warberg Asset Management LLC | 14,000 | $25,000 | 0.01% |
Alpha Cubed Investments, LLC | 10,000 | $18,000 | 0.00% |
Integrated Advisors Network LLC | 10,700 | $19,000 | 0.00% |
Core Wealth Advisors, Inc. | 550 | $1,000 | 0.00% |
OSAIC HOLDINGS, INC. | 5,000 | $9,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 41 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |